Scott A Tomlins Selected Research

Proto-Oncogene Proteins c-ets

2/2015	Reprint of: The prostate cancer genome: Perspectives and potential.
1/2014	The prostate cancer genome: perspectives and potential.
10/2012	Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer models.
5/2010	An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.
11/2009	Induced chromosomal proximity and gene fusions in prostate cancer.
9/2009	Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma.
8/2009	ETS gene fusions in prostate cancer: from discovery to daily clinical practice.
9/2008	A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.
5/2008	Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer.
1/2008	Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Scott A Tomlins Research Topics

Disease

110	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 09/2003
101	Neoplasms (Cancer) 01/2022 - 06/2004
14	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2007
13	Adenoma (Adenomas) 11/2020 - 08/2015
12	Carcinoma (Carcinomatosis) 01/2021 - 08/2009
9	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2003
9	Hyperaldosteronism (Conn Syndrome) 11/2020 - 01/2017
9	Adenocarcinoma 12/2019 - 02/2005
8	Carcinogenesis 01/2018 - 11/2006
7	Disease Progression 01/2022 - 05/2007
7	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 05/2009
5	Circulating Neoplastic Cells 01/2022 - 09/2016
4	Retinoblastoma (Glioblastoma, Retinal) 01/2022 - 02/2012
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 11/2016
4	Prostatic Intraepithelial Neoplasia 08/2012 - 02/2008
3	Lymphatic Metastasis 01/2018 - 09/2006
3	Leiomyomatosis 01/2018 - 11/2016
3	Lymphoma (Lymphomas) 01/2017 - 06/2013
3	Fibrosis (Cirrhosis) 11/2016 - 04/2004
2	Merkel Cell Carcinoma 01/2021 - 03/2016
2	Endometrioid Carcinoma 01/2020 - 11/2015
2	Adrenocortical Adenoma (Disease, Conn's) 01/2020 - 03/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2018 - 12/2015
2	Hyperplasia 10/2018 - 01/2017
2	Hypertension (High Blood Pressure) 07/2017 - 01/2017
2	Sarcoma (Soft Tissue Sarcoma) 12/2016 - 07/2010
2	Margins of Excision 11/2016 - 01/2015
2	Inflammation (Inflammations) 07/2015 - 04/2004
2	familial Prostate cancer 06/2014 - 05/2014
2	Leukemia 06/2013 - 07/2010
2	Hypoxia (Hypoxemia) 11/2012 - 02/2006
1	Gynecomastia 01/2022
1	Fatigue 01/2022
1	Urogenital Neoplasms 05/2021

Drug/Important Bio-Agent (IBA)

29	AndrogensIBA 01/2021 - 06/2004
25	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2003
23	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2006
19	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 11/2006
19	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 09/2006
17	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2006
15	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 05/2010
15	AldosteroneIBA 11/2020 - 08/2015
12	Biological ProductsIBA 01/2020 - 01/2006
12	Proto-Oncogene Proteins c-etsIBA 02/2015 - 10/2005
11	Formaldehyde (Formol)FDA Link 11/2021 - 03/2015
11	ParaffinIBA 11/2021 - 03/2015
11	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 08/2020 - 08/2015
11	Kazal Pancreatic Trypsin InhibitorIBA 12/2019 - 02/2008
9	Messenger RNA (mRNA)IBA 01/2020 - 03/2004
9	Transcription Factors (Transcription Factor)IBA 10/2016 - 09/2007
7	AntigensIBA 01/2021 - 08/2011
6	Hormones (Hormone)IBA 01/2021 - 06/2004
6	ChromatinIBA 01/2019 - 07/2010
5	Serine Proteases (Serine Protease)IBA 11/2015 - 08/2008
4	enzalutamideIBA 01/2022 - 01/2019
4	Phenobarbital (Luminal)FDA Link 01/2019 - 12/2017
4	Fumarate Hydratase (Fumarase)IBA 01/2019 - 11/2016
4	5' Untranslated Regions (5' UTR)IBA 11/2009 - 10/2005
4	Complementary DNA (cDNA)IBA 02/2006 - 04/2004
3	Estrogen ReceptorsIBA 01/2022 - 06/2009
3	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2020 - 08/2016
3	Cell-Free Nucleic AcidsIBA 01/2020 - 09/2016
3	Pharmaceutical PreparationsIBA 01/2020 - 05/2007
3	Phosphotransferases (Kinase)IBA 01/2019 - 06/2013
3	Testosterone (Sustanon)FDA Link 01/2019 - 10/2012
3	ErbB Receptors (EGF Receptor)IBA 04/2015 - 04/2005
3	ElementsIBA 11/2012 - 04/2004
2	B7-H1 AntigenIBA 01/2020 - 10/2018
2	Histones (Histone)IBA 01/2020 - 07/2012
2	Immune Checkpoint InhibitorsIBA 01/2020 - 06/2018
2	abirateroneIBA 01/2020 - 01/2019
2	bicalutamide (Casodex)FDA LinkGeneric 01/2019 - 10/2012
2	Small Interfering RNA (siRNA)IBA 01/2019 - 11/2012
2	Docetaxel (Taxotere)FDA Link 01/2019 - 01/2016
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2018 - 06/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2017 - 09/2004
2	ReninIBA 01/2017 - 08/2015
2	EnzymesIBA 01/2017 - 03/2004
2	MicroRNAs (MicroRNA)IBA 12/2015 - 08/2011
2	Membrane Proteins (Integral Membrane Proteins)IBA 11/2012 - 11/2008
2	Tissue ExtractsIBA 11/2005 - 03/2004
2	Tyrosine Kinase InhibitorsIBA 04/2005 - 09/2004
2	alpha-methylacyl-CoA racemaseIBA 09/2004 - 03/2004
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	AZD9496IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	palbociclibIBA 01/2021

Therapy/Procedure

33	Therapeutics 01/2022 - 05/2007
24	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 10/2006
18	Castration 01/2022 - 02/2012
9	Precision Medicine 01/2022 - 05/2015
3	Drug Therapy (Chemotherapy) 01/2020 - 09/2004
3	Lasers (Laser) 09/2007 - 01/2007
2	Adrenalectomy 11/2020 - 10/2018
2	Immunotherapy 01/2020 - 01/2019
2	Radiotherapy 01/2019 - 11/2016
2	Lymph Node Excision (Lymph Node Dissection) 01/2018 - 08/2017
1	Semiconductors 11/2021